
News|Articles|May 1, 2011
Formulary Digital Edition May 2011
A review of systemic lupus erythematosus and current treatment options; Bazedoxifene: An investigational selective estrogen receptor modulator for the treatment and prevention of osteoporosis in postmenopausal women; Agents in late-stage development for the treatment of major depressive disorder and generalized anxiety disorder
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Healthcare's AI push is creating a new workforce challenge
2
4 things to know about the Abarca/LucyRx merger
3
EHR-based risk calculator reduces 3-year diabetes risk in patients with prediabetes
4
FDA expands Capvaxive indication to include adolescent patients at risk for pneumococcal disease
5
































